Drug Pipeline

M7824 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
8
Active Studies
3
Recruiting
2
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-19 NCT04432597
HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in…
date change Completion pushed: 2026-03-31 -> 2026-05-29
Active Studies by Phase
Phase 2
1
Phase 1/2
5
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT04417660 Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma Thymic Epithelial Tumor Active, Not Recruiting
Phase 1/2
NCT04633252 A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic… Cancer Of Prostate Recruiting
NCT04303117 PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma Kaposi Sarcoma Recruiting
NCT04708470 A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including… Oropharyngeal Cancer Active, Not Recruiting
NCT04287868 Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies Cervical Cancer Active, Not Recruiting
NCT04432597 HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in… HPV Positive Cancer Active, Not Recruiting
Phase 1
NCT04235777 Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body… Urothelial Cancer Recruiting
NCT04708067 Hypofractionated Radiation Therapy and Bintrafusp Alfa for the Treatment of Advanced… Locally Advanced Intrahepatic Cholangiocarcinoma Active, Not Recruiting
Sponsors Running M7824 Trials
Disease Areas
Get alerts when M7824 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free